MUC1‐specific anti‐tumor responses: molecular requirements for CD4‐mediated responses

By VanLith Michelle L.   Kohlgraf Karl G.   Sivinski Connie L.   Tempero Richard M.   Hollingsworth Michael A.  

International Immunology, Vol. 14, Iss. 8, 2002-08 ,pp. : 873-882

Oxford University Press

Access to resources Recommend Favorite

A novel tumor-vaccine cell therapy using bone marrow-derived dendritic cell type 1 and antigen-specific T h 1 cells

By Sato M.   Chamoto K.   Nishimura T.  

International Immunology, Vol. 15, Iss. 7, 2003-07 ,pp. : 837-843

Oxford University Press

Access to resources Recommend Favorite

Potent Systemic Antitumor Immunity Induced by Vaccination with Chemotactic-Prostate Tumor Associated Antigen Gene-Modified Tumor Cell and Blockade of B7-H1

By LI NING   QIN HANJUN   LI XIAOZHU   ZHOU CHUNXIA   WANG DONGMEI   MA WENBO   LIN CHEN   ZHANG YOUHUI   WANG SHENGDIAN   ZHANG SHUREN  

Journal of Clinical Immunology, Vol. 27, Iss. 1, 2007-01 ,pp. : 117-130

Springer Publishing Company

Access to resources Recommend Favorite

Histone acetylation regulates the cell type specific CIITA promoters, MHC class II expression and antigen presentation in tumor cells

By Chou Shiuh-Dih   Khan A. Nazmul H.   Magner William J.   Tomasi Thomas B.  

International Immunology, Vol. 17, Iss. 11, 2005-11 ,pp. : 1483-1494

Oxford University Press

Access to resources Recommend Favorite

Tumor immunity meets autoimmunity: antigen levels and dendritic cell maturation

By Spiotto M.T.   Fu Y.-X.   Schreiber H.  

Current Opinion in Immunology, Vol. 15, Iss. 6, 2003-12 ,pp. : 725-730

Elsevier

Access to resources Recommend Favorite